Modulation by endogenous nitric oxide of acid secretion induced by gastric distention in rats: enhancement by nitric oxide synthase inhibitor
- PMID: 10490902
Modulation by endogenous nitric oxide of acid secretion induced by gastric distention in rats: enhancement by nitric oxide synthase inhibitor
Abstract
The mechanism underlying acid hypersecretion induced by gastric distention was investigated in rats, especially in relation to endogenous nitric oxide (NO). Under urethane anesthesia, rat stomach was distended by instillation of saline (1-10 ml) through the acute fistula that was provided through a pylorus. Gastric samples were collected every 1 h, and the acid secretion was measured by titration with 100 mM NaOH. Gastric acid secretion was increased by distention, and the degree of stimulation was dependent on the volume of saline instillation; a maximal response occurred with 6-ml instillation, which maintained the intraluminal pressure of about 20 cm H(2)O. The increased acid secretory response induced by distention was completely blocked by omeprazole and significantly mitigated by vagotomy, sensory deafferentation, atropine, or famotidine but markedly enhanced by the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME). On the other hand, the enhanced acid response in the presence of L-NAME occurred in an L-arginine-sensitive manner and was almost totally abolished by vagotomy and sensory deafferentation as well as by atropine. Gastric distention increased the release of NO metabolites and histamine into the gastric lumen. The NO metabolite release in the distended stomach was significantly decreased by vagotomy or L-NAME, whereas the histamine output was decreased by vagotomy but increased by L-NAME in an L-arginine-sensitive manner, respectively. These results suggest that 1) gastric distention increases acid secretion, initially through the perception by sensory neurons of the mechanical stimulation and mainly through the efferent vagocholinergic pathway, with the process being modified by endogenous NO, and 2) this molecule, released in a vagal-dependent manner, exerts a negative influence on acid secretion, at least in part by suppressing histamine release from the histamine-containing cells.
Similar articles
-
Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor.Br J Pharmacol. 1998 Mar;123(5):839-46. doi: 10.1038/sj.bjp.0701691. Br J Pharmacol. 1998. PMID: 9535011 Free PMC article.
-
Gastric hyperemic response during vagally mediated acid secretion by TRH analog in rats.J Pharmacol Exp Ther. 1997 Sep;282(3):1351-7. J Pharmacol Exp Ther. 1997. PMID: 9316846
-
Dual role of nitric oxide in gastric hypersecretion in the distended stomach: inhibition of acid secretion and stimulation of pepsinongen secretion.Life Sci. 2008 Dec 19;83(25-26):886-92. doi: 10.1016/j.lfs.2008.10.010. Epub 2008 Oct 30. Life Sci. 2008. PMID: 19000699
-
Cholinergic control of gastric acid secretion in man.Scand J Gastroenterol Suppl. 1982;72:1-5. Scand J Gastroenterol Suppl. 1982. PMID: 6753111 Review.
-
Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide.Trends Pharmacol Sci. 1998 Oct;19(10):403-5. doi: 10.1016/s0165-6147(98)01249-8. Trends Pharmacol Sci. 1998. PMID: 9803830 Review.
Cited by
-
Activation of Muscarinic Acetylcholine Receptor Subtype 4 Is Essential for Cholinergic Stimulation of Gastric Acid Secretion: Relation to D Cell/Somatostatin.Front Pharmacol. 2016 Aug 30;7:278. doi: 10.3389/fphar.2016.00278. eCollection 2016. Front Pharmacol. 2016. PMID: 27625606 Free PMC article.
-
Nitric Oxide and Hydrogen Sulfide Interact When Modulating Gastric Physiological Functions in Rodents.Dig Dis Sci. 2017 Jan;62(1):93-104. doi: 10.1007/s10620-016-4377-x. Epub 2016 Nov 18. Dig Dis Sci. 2017. PMID: 27864656
-
Gastric secretions affected by esophageal distention in the rat.J Gastroenterol. 2009;44(2):132-8. doi: 10.1007/s00535-008-2288-0. Epub 2009 Feb 13. J Gastroenterol. 2009. PMID: 19214675
-
Anaesthetic agents inhibit gastrin-stimulated but not basal histamine release from rat stomach ECL cells.Br J Pharmacol. 2000 Jun;130(4):725-30. doi: 10.1038/sj.bjp.0703347. Br J Pharmacol. 2000. PMID: 10864877 Free PMC article.